✦ LIBER ✦

Phase I and pharmacokinetic study of intraperitoneal thioTEPA in patients with ovarian cancer

✍ Scribed by Craig Lewis; Nora Lawson; Elaine M. Rankin; Gilmour Morrison; Allan B. MacLean; James Cordiner; James Cassidy; David J. Kerr; Stanley B. Kaye

Publisher: Springer
Year: 1990
Tongue: English
Weight: 554 KB
Volume: 26
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf02897231

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of intraperitoneal hype

Pharmacokinetics of intraperitoneal hyperthermic perfusion with mitoxantrone in ovarian cancer

✍ M. O. Nicoletto; R. Padrini; F. Galeotti; E. Ferrazzi; G. Cartei; F. Riddi; M. P 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 96 KB

Phase I and pharmacokinetic study of d-l

Phase I and pharmacokinetic study of d-limonene in patients with advanced cancer

✍ David M. Vigushin; Grace K. Poon; Alan Boddy; Jacqueline English; Gavin W. Halbe 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 307 KB

Improvement in intraperitoneal intraoper

Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer

✍ Bernard Royer; Delphine Delroeux; Emmanuel Guardiola; Marielle Combe; Guillaume 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 286 KB

Phase I study of the tolerance and pharm

Phase I study of the tolerance and pharmacokinetics of toremifene in patients with cancer

✍ Peter C. Kohler; John T. Hamm; Valerie J. Wiebe; Michael W. DeGregorio; Irving S 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 590 KB

Intraperitoneal administration of interf

Intraperitoneal administration of interferon β in ovarian cancer patients

✍ Alessandro Rambaldi; Martino Introna; Francesco Colotta; Santo Landolfo; Nicolet 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 670 KB

Phase I and pharmacokinetic study of hig

Phase I and pharmacokinetic study of high volume intraperitoneal aclacinomycin — A (Aclarubicin)

✍ Ian G. Kerr; Sherry Archer; Carlo DeAngelis; Susan Farrell; Sherif Hanna; John M 📂 Article 📅 1987 🏛 Springer US 🌐 English ⚖ 379 KB

Aclacinomycin-A (Aclarubicin) is a relatively new anthracycline antibiotic with potential activity against ovarian cancer. Eight patients with various malignancies (4 ovary, 1 breast and ovary, 1 breast, 1 colon, 1 leiomyosarcoma) and intraperitoneal disease were treated in a Phase I trial with esca